TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$39.86B
Stockholders' Equity
$7.75B
Cash & Equivalents
$3.65B
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, TEVA PHARMACEUTICAL INDUSTRIES LTD reported revenue of $4.14B, net income of -$576.0M, and total assets of $39.86B. Every figure below is taken directly from TEVA PHARMACEUTICAL INDUSTRIES LTD's SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2016–FY2025 · as reported

$22.39B$3.06B-$16.27B
FY2016FY2019FY2022FY2025
Revenue$17.26BNet income$1.41B
FY2016 revenue
$21.90B
FY2025 revenue
$17.26B

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$17.26B$1.41B
FY2024$16.54B-$1.64B
FY2023$15.85B-$559.0M
FY2022$14.93B-$2.45B
FY2021$15.88B$417.0M
FY2020$16.66B-$3.99B
FY2019$16.89B-$999.0M
FY2018$18.27B-$2.15B
FY2017$22.39B-$16.27B
FY2016$21.90B$329.0M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KOct 29, 2026on EDGAR ↗
8-KSep 16, 2026on EDGAR ↗
8-KSep 14, 2026on EDGAR ↗
8-KSep 11, 2026on EDGAR ↗
8-KSep 3, 2026on EDGAR ↗
8-KSep 3, 2026on EDGAR ↗
8-KJul 29, 2026on EDGAR ↗
10-QJul 29, 2026on EDGAR ↗
8-KMay 28, 2026on EDGAR ↗
10-QApr 29, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$39.86Bsource ↗
Stockholders’ Equity$7.75Bsource ↗
Cash & Equivalents$3.65Bsource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue$4.14Bsource ↗
Net Income-$576.0Msource ↗
Operating Income-$231.0Msource ↗
Gross Profit$2.15Bsource ↗
Cost of Revenue$1.99Bsource ↗
R&D Expense$970.0Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-0.49source ↗
EPS (basic)$-0.49source ↗
Shares Outstanding1.17Bsource ↗
Cash from Operations$411.0Msource ↗
Cash from Financing-$1.0Msource ↗
Cash from Investing-$491.0Msource ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
0
Sells
20
Net shares
-816.3K

Restatement history

Point-in-time

18 of 359 annual fact-keys were materially restated between filings: what TEVA PHARMACEUTICAL INDUSTRIES LTD first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches TEVA’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/TEVA

MCP tool: get_sec_fundamentals ticker=TEVA

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/TEVA/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=TEVA as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/TEVA/history

MCP tool: get_fundamentals_history ticker=TEVA

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/TEVA

MCP tool: get_financial_health ticker=TEVA

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.